As Coronavirus (COVID-19) is now a global pandemic - with the United States presenting the most significant number of cases - I am reminded of current and past experiences implementing contract management software to help organizations with clinical trials and drug development tracking. Organizations in the medical field, healthcare, pharmaceuticals, biopharmaceuticals, and other related industries need to effectively manage drug development contracts and obligations, clinical trials, manufacturing of medicine, and key opinion leaders globally. CobbleStone’s leading enterprise contract lifecycle management software provides the solution to these challenges.
Manually managing purchase orders, bids, vendors, and contracts can be difficult. Processes that involve paying per solicitation can become extremely costly. Limited visibility leaves your organization with an imperfect pool of vendors. Hindrances such as an inadequate sourcing platform, an overly complicated procurement system database, and an inefficient contract lifecycle process can prevent your organization from properly administering its contracts. An effectual source-to-contract process is the solution to the abovementioned issues. CobbleStone Software’s Contract Insight can provide that solution.